Bio-Rad Laboratories Inc (BIO-B)vsGE HealthCare Technologies Inc. (GEHC)
BIO-B
Bio-Rad Laboratories Inc
$268.55
0.00%
HEALTHCARE · Cap: $6.63B
GEHC
GE HealthCare Technologies Inc.
$72.20
+1.75%
HEALTHCARE · Cap: $32.38B
Smart Verdict
WallStSmart Research — data-driven comparison
GE HealthCare Technologies Inc. generates 712% more annual revenue ($20.63B vs $2.54B). GEHC leads profitability with a 10.1% profit margin vs -85.2%. BIO-B appears more attractively valued with a PEG of 1.21. GEHC earns a higher WallStSmart Score of 60/100 (C+).
BIO-B
Hold37
out of 100
Grade: F
GEHC
Buy60
out of 100
Grade: C+
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Intrinsic value data unavailable for BIO-B.
Margin of Safety
-156.0%
Fair Value
$30.94
Current Price
$72.20
$41.26 premium
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Conservative balance sheet, low leverage
Every $100 of equity generates 22 in profit
Attractively priced relative to earnings
Areas to Watch
ROE of -27.5% — below average capital efficiency
Revenue declined 4.2%
Earnings declined 83.0%
Currently unprofitable
Expensive relative to growth rate
Weak financial health signals
Earnings declined 17.7%
Distress zone — elevated risk
Comparative Analysis Report
WallStSmart ResearchBull Case : BIO-B
The strongest argument for BIO-B centers on Price/Book, Debt/Equity. PEG of 1.21 suggests the stock is reasonably priced for its growth.
Bull Case : GEHC
The strongest argument for GEHC centers on Return on Equity, P/E Ratio.
Bear Case : BIO-B
The primary concerns for BIO-B are Return on Equity, Revenue Growth, EPS Growth.
Bear Case : GEHC
The primary concerns for GEHC are PEG Ratio, Piotroski F-Score, EPS Growth.
Key Dynamics to Monitor
BIO-B profiles as a turnaround stock while GEHC is a value play — different risk/reward profiles.
GEHC carries more volatility with a beta of 1.18 — expect wider price swings.
GEHC is growing revenue faster at 7.1% — sustainability is the question.
GEHC generates stronger free cash flow (917M), providing more financial flexibility.
Bottom Line
GEHC scores higher overall (60/100 vs 37/100). Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Bio-Rad Laboratories Inc
HEALTHCARE · MEDICAL DEVICES · USA
Bio-Rad Laboratories, Inc. is an American developer and manufacturer of specialized technological products for the life science research and clinical diagnostics markets.
Visit Website →GE HealthCare Technologies Inc.
HEALTHCARE · MEDICAL DEVICES · USA
GE HealthCare Technologies Inc. provides medical technology, pharmaceutical diagnostics, and digital solutions in the United States. The company is headquartered in Chicago, Illinois.
Compare with Other MEDICAL DEVICES Stocks
Want to dig deeper into these stocks?